Trials / Completed
CompletedNCT00171470
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Study to provide initial data to assess the safety and efficacy of tegaserod use in patients with dyspepsia that are being treated with proton pump inhibitors (PPI's) for heartburn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegaserod |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-08-01
- First posted
- 2005-09-15
- Last updated
- 2008-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00171470. Inclusion in this directory is not an endorsement.